Back

Long-Acting Injectable Buprenorphine Use and Treatment Attribute Priorities Among U.S. Buprenorphine Prescribers: A National Survey

2026-02-03 addiction medicine Title + abstract only
View on medRxiv
Show abstract

BackgroundLong-acting injectable buprenorphine (LAI-BUP) is safe and effective, however is dramatically underutilized in comparison to oral formulations. Little is known regarding how buprenorphine prescribers view LAI-BUP, and which medication attributes they prioritize when selecting treatment for opioid use disorder (OUD). MethodsA secondary analysis of a national, cross-sectional online survey of U.S. physicians who prescribe buprenorphine for OUD was conducted. Respondents reported OUD cas...

Predicted journal destinations